Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Serabelisib

Copy Product Info
🥰Excellent
Catalog No. T3153Cas No. 1268454-23-4
Alias TAK-117, MLN1117, INK1117

Serabelisib (INK1117) is a p110α/β/γ/δ inhibitor (IC50: 15/4.5/1.9/13.39 μM).

Serabelisib

Serabelisib

Copy Product Info
🥰Excellent
Purity: 99.5%
Catalog No. T3153Alias TAK-117, MLN1117, INK1117Cas No. 1268454-23-4
Serabelisib (INK1117) is a p110α/β/γ/δ inhibitor (IC50: 15/4.5/1.9/13.39 μM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35In StockIn Stock
5 mg$56In StockIn Stock
10 mg$89In StockIn Stock
25 mg$179In StockIn Stock
50 mg$289In StockIn Stock
100 mg$455In StockIn Stock
1 mL x 10 mM (in DMSO)$62In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.5%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Serabelisib AI Summary
Serabelisib is a potent inhibitor of PI3Kalpha, exhibiting an IC50 value of 15.0 nM. It also inhibits PI3Kgamma and PI3Kbeta, though with lower potency, having IC50 values of 1900.0 nM and 4500.0 nM, respectively. In addition to its kinase inhibition, Serabelisib displays antiviral activity against SARS-CoV-2 by inhibiting virus-induced cytotoxicity in Caco-2 and VERO-6 cells at a concentration of 10 µM after 48 hours. However, it showed a negative inhibition rate of -6.96% and -0.04% in these assays, respectively. The compound also targets the SARS-CoV-2 3CL-Pro protease, with a -1.773% inhibition at 20 µM concentration. Additionally, Serabelisib exhibits 17.75% inhibition of the human HDAC6 enzyme using a commercial peptide substrate, but presents a slight negative inhibition of -4.62% when tested with a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Serabelisib (INK1117) is a p110α/β/γ/δ inhibitor (IC50: 15/4.5/1.9/13.39 μM).
Targets&IC50
p110δ:13.39 μM, p110α:15μM, p110γ:1.9μM, mTOR:1670 nM, p110β:4.5μM
SynonymsTAK-117, MLN1117, INK1117
Chemical Properties
Molecular Weight363.37
FormulaC19H17N5O3
Cas No.1268454-23-4
SmilesC(=O)(C=1N2C(=NC1)C=CC(=C2)C=3C=C4C(=CC3)OC(N)=N4)N5CCOCC5
Relative Density.1.55 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5 mg/mL (13.76 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7520 mL13.7601 mL27.5202 mL137.6008 mL
5 mM0.5504 mL2.7520 mL5.5040 mL27.5202 mL
10 mM0.2752 mL1.3760 mL2.7520 mL13.7601 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Serabelisib | purchase Serabelisib | Serabelisib cost | order Serabelisib | Serabelisib chemical structure | Serabelisib formula | Serabelisib molecular weight